ASCO Annual Meeting 2017
Jun 02, 2017
June 2 – 6, 2017
McCormick Place
Chicago, Illinois
Exhibit booth #25105
Posters:
DATE, PLACE and TIME:
Monday, June 5,2017, Hall A, 1:15pm – 4:45pm CST
Session: Genitourinary (Prostate) Cancer
Abstract #: 50770
Board #: 144
Howard I. Scher, Adam Jendrisak, Nicole A. Schreiber, Brigit McLaughlin, Ryon P Graf, Angel Rodriguez, Martin Fleisher, Jerry Lee, James Kelvin, Yipeng Wang, Mark Andrew Landers, Ryan Dittamore; Memorial Sloan-Kettering Cancer Center, New York, NY; Epic Sciences, Inc., San Diego, CA
DATE, PLACE and TIME:
Monday, June 5,2017, Hall A, 1:15pm – 4:45pm CST
Session: Genitourinary (Prostate) Cancer
Abstract #: 5076
Board #: 150
Ryan Dittamore, Adam Jendrisak, Nicole A. Schreiber, Brigit McLaughlin, Ryon Graf, Angel Rodriguez, Martin Fleisher, Jerry Lee, James Kelvin, Yipeng Wang, Mark Andrew Landers, Howard I. Scher; Epic Sciences, Inc., San Diego, CA; Memorial Sloan-Kettering Cancer Center, New York, NY
DATE, PLACE and TIME:
Monday, June 5,2017, Hall A, 1:15pm – 4:45pm CST
Session: Genitourinary (Prostate) Cancer
Abstract #: 5035
Board #: 109
Phase 2 biomarker-driven study of ipilimumab plus nivolumab (Ipi/Nivo) for ARV7-positive metastatic castrate-resistant prostate cancer (mCRPC).
Karim Boudadi, Daniel L. Suzman, Brandon Luber, Hao Wang, John Silberstein, Rana Sullivan, Donna Dowling, Rana Harb, Thomas Nirschl, Ryan Dittamore, Michael Anthony Carducci, Mario A. Eisenberger, Michael Haffner, Alan Meeker, James R. Eshleman, Jun Luo, Charles G. Drake, Emmanuel S. Antonarakis; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Johns Hopkins University, Baltimore, MD; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; Epic Sciences, Inc., San Diego, CA; The Johns Hopkins University School of Medicine, Baltimore, MD; Johns Hopkins University School of Medicine, Baltimore, MD; Department of Urology, The John Hopkins University School of Medicine, Baltimore, MD; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY
DATE, PLACE and TIME:
Monday, June 5,2017, Hall A, 1:15pm – 4:45pm CST
Session: Genitourinary (Prostate) Cancer
Abstract #: 5034
Board #: 108
Susan F. Slovin, Karen E. Knudsen, Susan Halabi, Emily Carbone, Celina Fernandez, Yu Chen, Karen A. Autio, Dana E. Rathkopf, Lewis J. Kampel, Michael J. Morris, Gabrielle Arauz, Ryon P Graf, James Kelvin, Ryan Dittamore, Renee De Leeuw, Amanda Sullivan, Kin Tse, Ana M. Molina, Howard I. Scher, William Kevin Kelly; Memorial Sloan-Kettering Cancer Center, New York, NY; The Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA; Duke University Medical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical College, New York, NY; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University; Memorial Sloan-Kettering Cancer Center, New York, NY; Epic Sciences, Inc., San Diego, CA; Thomas Jefferson University Kimmel Cancer Center, Philadelphia, PA; Prostate Cancer Clinical Trials Consortium, LLC, New York, NY; Weill Cornell Medical College, New York, NY